Wells Fargo & Company Orchard Therapeutics PLC Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.7 - $1.51 $8,049 - $17,365	11,500 Added 1150.0%	12,500 $9,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $300 - $577	-259 Reduced 20.57%	1,000 $1,000
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $927 - $1,776	-414 Reduced 24.75%	1,259 $3,000
Q1 2021 May 13, 2021	SELL	$4.39 - $9.08 $377 - $780	-86 Reduced 4.89%	1,673 $12,000
Q3 2020 Nov 05, 2020	BUY	$4.11 - $6.45 $4,352 - $6,830	1,059 Added 151.29%	1,759 $7,000
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $3,955 - $10,997	700 New	700 $5,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.